Poison Ivy or Oak

Poison Ivy and Poison Oak (Toxicodendron Dermatitis): A Natural-Health Reference

Definition and Overview

Poison ivy, poison oak, and poison sumac are types of American plants that each grow in different parts of the country, and they cause allergic contact dermatitis in most people who touch them. All of these plants fall into the plant genus called Toxicodendron, so the allergic reaction to all of them shares the same name: Toxicodendron dermatitis.

The genus Toxicodendron species include Western and Eastern poison oak (T. diversilobum), poison ivy (T. radicans), and poison sumac (T. vernix), distributed widely across North America. Other sources of urushiol include poisonwood (in Florida and the Bahamas) and the sap of the Asian lacquer tree used as varnish in Japanese lacquerware, as well as cashew nut shells.

Urushiol-induced allergic contact dermatitis in the United States most commonly results from unexpected exposure to oils from plants in the sumac family Anacardiaceae, with approximately 10 to 50 million Americans suffering from rashes resulting from exposure every year.

The Causative Agent: Urushiol

Poison ivy leaves are coated with a mixture of chemicals called urushiol. When people get urushiol on their skin, it causes an allergic contact dermatitis. When located inside an unruptured plant, urushiol is a light, colorless oil. When exposed to oxygen, urushiol easily oxidizes and, after polymerizing, turns a blackish color.

Urushiol is found not only in the leaves but also in the vines and stem and root systems. The urushiol in the root system and vines is pure and is ten to one hundred times more potent than that found in leaves.

Poison ivy urushiol is mostly composed of pentadec(en)yl catechols. The allergenic components in most of these plants are 3-n-alk-(en)-yl catechols with C-15 or C-17 side chains and different degrees of unsaturation (zero to three olefinic bonds). Both the catecholic ring and the aliphatic chain are proven to play important roles in the allergenicity of urushiols.

The oil adheres to almost anything with which it comes in contact, such as towels, blankets, clothing, and landscaping tools. Common causes of exposure are clothing or other materials that touch the plant and then, before being washed, touch the skin. Airborne contact from burning these plants releases particles of urushiol into the air that can penetrate the skin, eyes, nose, throat, or respiratory system.

Clinical Presentation

The first time you touch one of the plants, you may not get a rash, because your body's allergic response is not yet sensitive to it. The next time you touch one of the plants, your body may react in 24 to 72 hours. Delayed hypersensitivity does not start to be noticeable until several hours to a full day after exposure to the antigen, and it may last for over a week.

The rash takes one to two weeks to run its course and may cause scars, depending on the severity of the exposure. Severe cases involve small (1–2 mm), clear, fluid-filled blisters on the skin. Pus-filled vesicles containing a whitish fluid may indicate an infection. Most poison ivy rashes, without infections, will resolve within 14 days without treatment. Excessive scratching may result in infection, commonly by staphylococcal and streptococcal species, which may require antibiotics.

Symptoms of allergic contact dermatitis from urushiol exposure vary from a mild annoyance to weeks of irritation and pain. Occasionally, exposure can lead to nephropathy and even to fatal systemic anaphylaxis.

Allergic contact dermatitis from urushiol occurs more commonly on thin-skin surfaces such as eyelids and genital skin. The rash cannot spread from one person to another, but plant oils on skin and clothes can pass from one person to another and cause a rash.

Body Systems Involved

The Immune System

The reaction is a T cell-mediated immune response, also called delayed hypersensitivity, in which the body's immune system recognizes as foreign, and attacks, the complex of urushiol-derivatives with skin proteins.

During sensitization, dendritic cells (DCs) that have taken up urushiol migrate to draining lymph nodes where they mature, express co-stimulatory molecules, and present antigens to naïve T cells. The mature DCs as well as the naïve T cells are attracted to the lymph nodes by chemokines. When a sensitized person is exposed to urushiol, specific T cells (CD8+ and CD4+) migrate under the influence of chemokines to the site of exposure on the skin where the cells undergo extensive proliferation. The activated T cells subsequently produce and release high levels of cytokines, causing an inflammatory process leading to inflammation and/or edema.

It has been suggested that CD8+ cytotoxic lymphocytes are the main effector cells responsible for the manifestation of allergic contact dermatitis. These cells are recruited early after challenge.

T lymphocytes pour out inflammatory signal substances called cytokines, which call in armies of white blood cells called monocytes, which become macrophages.

The Skin (Integumentary System)

Urushiol is fat-soluble, penetrating the stratum corneum of the skin, then binding to Langerhans cells in the epidermis. The lipophilic urushiol antigens are internalized by Langerhans cells (skin macrophages) through endocytosis, with the antigen subsequently degraded and presented to T-lymphocytes.

The Lymphatic System

The Langerhans cell (with urushiol allergen and MHC protein on its membrane) migrates to a nearby lymph node where clones of special white blood cells, called effector T-cells, are programmed to recognize urushiol.

Cross-Reactive Dietary and Environmental Sources

People who are sensitive to urushiol can also experience a similar rash from mangoes, with the tree's sap and fruit's skin containing a similar chemical compound. A related allergenic compound is present in the raw shells of cashews. Contact of these catechols with the skin of susceptible individuals results in sensitization to all urushiols of the plant family Anacardiaceae.

Contributing and Associated Factors

Sensitization and Prior Exposure

Allergic contact dermatitis requires prior exposure to a plant chemical, like urushiol, which sensitizes the immune system. As a result, antibodies form, leading to more severe responses to the allergen with additional exposures. Once sensitivity is developed, it is difficult, if not impossible, to eliminate.

Age

Peak frequency for sensitization occurs between 8 and 14 years of age. Infants are apparently not as easily sensitized as adults.

Genetics

Genetic susceptibility to urushiol sensitivity has been suggested by the finding that 80% of children who are born to two urushiol-sensitive parents will become sensitive. Many questions remain about the relationship between a worker's age, health status, environmental conditions, and their susceptibility to poisonous plants.

Occupational and Recreational Risk

Workers at risk include construction workers, farmers, landscapers and arborists, gardeners, outdoor painters, roofers, and wildland firefighters. Toxicodendron dermatitis causes 10% of total US Forest Services lost-time injuries, and approximately one third of forestry workers in California, Oregon, and Washington are disabled by poison oak dermatitis each fire season.

Climate Change and Increasing Allergen Potency

In a 6-year study at the Duke University Free-Air CO₂ Enrichment experiment, elevated atmospheric CO₂ in an intact forest ecosystem was shown to increase photosynthesis, water use efficiency, growth, and population biomass of poison ivy. The CO₂ growth stimulation exceeds that of most other woody species. Furthermore, high-CO₂ plants produce a more allergenic form of urushiol. These results indicate that Toxicodendron taxa will become more abundant and more "toxic" in the future, potentially affecting global forest dynamics and human health.

A nonsignificant increase in urushiol concentration was observed in response to CO₂; however, because of the stimulatory effect of CO₂ on leaf biomass, the total amount of urushiol produced per plant increased significantly for all CO₂ levels above the 300 µmol mol⁻¹ baseline.

Nutrients, Herbs, and Natural Ingredients: Traditional Use and Scientific Evidence

Jewelweed (Impatiens capensis / I. biflora)

Traditional Use

Many different tribes of American Indians used jewelweed, Impatiens capensis, as a plant mash to reduce the development of poison ivy dermatitis. Jewelweed is native to the Eastern and Midwestern US and Canada. Many Native American tribes used I. capensis and its close relatives to treat and prevent rash from plant sources, particularly Toxicodendron radicans and Urtica dioica. I. balsamina (garden balsam), a native of China, was used by the indigenous people of Asia for similar purposes.

Scientific Evidence

Jewelweed (Impatiens biflora) is a plant that has been used for centuries for the treatment of poison ivy/oak allergic contact dermatitis. Numerous claims for its effectiveness exist in the lay press, and over-the-counter medicaments containing jewelweed are reputed to be effective remedies. Despite these claims, few scientific studies testing its effectiveness have been performed.

A pilot study objective was to test the efficacy of an extract of jewelweed in the treatment of experimentally induced allergic contact dermatitis to poison ivy/oak. A randomized, double-blinded, paired comparison investigation was performed. Ten adult volunteers were patch tested to urushiol. For each volunteer, one patch test site was treated with an extract prepared from fresh stems of jewelweed; the remaining site was treated with distilled water as a control.

Despite being used both traditionally and in modern times for the treatment of poison ivy and poison oak exposure, Impatiens sp. has not been found to be convincingly successful when used in the treatment of urushiol-induced contact dermatitis in multiple clinical evaluations (Long et al., 1997; Bedi & Shenefelt, 2002; Motz et al., 2012).

In another clinical trial, poison ivy rashes were induced on volunteers in six locations. These rashes were treated with jewelweed extracts, jewelweed mash, soap made from jewelweed extract, water, and Dawn dish soap. Only the jewelweed mash was found to have a significant effect in reducing dermatitis (Motz et al., 2012).

The proposed active agents have shifted in the literature. Lawsone content was found not to correlate with poison ivy rash prevention. Instead, saponins — the soapy component of jewelweed — are hypothesized to be the effective agents. A 2012 study suggested that saponins may be present in jewelweed, which could be responsible for its efficacy in preventing rash development following contact with Toxicodendron radicans.

Apigenin, luteolin, and luteolin 7-glucoside are found in the extract of the flower and exhibit significant allergy preventive effects observed in in vivo studies. An in vivo study showed kaempferol, isolated from the petals of Impatiens sp., inhibited scratching behavior in mice with atopic dermatitis, demonstrating anti-pruritic and anti-dermatitis properties.

Evidence strength: Mixed and limited. Human clinical evidence for jewelweed is inconsistent; the extract form has largely failed to show benefit, while fresh plant mash showed a statistically significant effect in one small trial. Animal and in vitro data for constituent flavonoids are preliminary.

Quercetin

Traditional Use

Quercetin is a naturally occurring flavonoid found in foods. Its main natural sources in foods are vegetables such as onions, broccoli, fruits including apples, berry crops and grapes, some herbs, tea, and wine. Its use specifically for urushiol-induced dermatitis does not have a well-documented traditional record; however, it has been broadly used in folk medicine as an anti-inflammatory and antihistamine agent.

Scientific Evidence

Quercetin is known for its antioxidant activity in radical scavenging and anti-allergic properties, characterized by stimulation of the immune system, antiviral activity, inhibition of histamine release, decrease in pro-inflammatory cytokines and leukotriene creation, and suppression of interleukin IL-4 production. It can improve the Th1/Th2 balance and restrain antigen-specific IgE antibody formation.

Mast cells play an essential role in contact hypersensitivity through complex interaction with different kinds of immune cells. In allergic contact dermatitis, mast cells regulate inflammatory reactions by releasing mediators like histamine, TNF-α, and IL-8, leading to local vascular activation and subsequent immune cell recruitment. Quercetin and its structurally related luteolin inhibit the release of histamine, leukotrienes, and PGD₂ from human cultured mast cells in response to cross-linkage of high-affinity surface IgE receptors. Quercetin also inhibits histamine, IL-6, IL-8, TNF-α, and tryptase release from human mast cells.

Research has shown that quercetin is more effective than cromolyn in inhibiting inflammatory cytokine release from human cultured mast cells.

In vitro studies have consistently demonstrated quercetin's ability to suppress allergic reactions. In contrast, in vivo studies, particularly in murine models of allergic rhinitis, have confirmed its efficacy in relieving symptoms and dampening type 2 mucosal inflammation. Preclinical evidence also supports its therapeutic potential in asthma, conjunctivitis, atopic dermatitis, and food allergies. However, human studies are still scarce, as only two clinical trials investigated quercetin as a monotherapy. Both studies reported promising results, including symptom reduction and improved quality of life, though larger, randomized trials are needed to validate these findings.

A systematic review following PRISMA guidelines provided thorough synthesis of preclinical evidence supporting quercetin's immunomodulatory actions in allergic diseases, with consistency in identification of modulated biomarkers across studies. However, caution is warranted, as the applicability of results to humans may be impacted by the characteristics of the animal models synthesized.

Evidence strength: Strong preclinical (in vitro and animal) evidence for anti-allergic and anti-inflammatory mechanisms relevant to contact dermatitis; human clinical evidence in contact dermatitis specifically is very limited. No randomized controlled trials have specifically evaluated quercetin for urushiol-induced dermatitis.

Vitamin C (Ascorbic Acid)

Traditional Use

Vitamin C has been used across many traditional medicine systems as a broad anti-inflammatory and immune-supporting agent, though it does not have a specific historical record of use for poison ivy or urushiol-induced dermatitis.

Scientific Evidence

Physiologically, vitamin C is involved in several immunoinflammatory reactions as an oxygen radical scavenger, including the degradation of histamine and a reduction of histamine-associated symptoms in allergic and infectious disease.

In a study investigating the acute effect of 7.5 g of intravenous vitamin C on the histamine levels in 89 patients with allergies or upper respiratory infections, a significant reduction in histamine levels was observed. Patients with atopic dermatitis and psoriasis reportedly have reduced cutaneous ascorbate levels.

However, evidence from oral supplementation is mixed. The effect of ascorbic acid on the skin wheal and flare response to histamine and allergen and on the nasal response to allergen was evaluated in eight adults with seasonal allergic rhinitis. Parameters were measured after 3 days of AA administration (2 g/day) and again after 3 days of placebo. An additional study examined subjects taking 0, 1, 2, and 4 g/day of AA to determine dose-response effects on histamine skin tests. The findings suggested that AA in relatively high doses would have no beneficial effects on symptoms resulting from allergen exposure and that AA in doses of up to 4 g/day would not suppress the histamine skin response.

Evidence strength: Preliminary. Intravenous vitamin C shows some histamine-reducing effects in allergic conditions; oral vitamin C has shown inconsistent results in clinical study. No studies have directly evaluated vitamin C for urushiol-induced contact dermatitis.

Colloidal Oatmeal (Avena sativa)

Traditional Use

Oatmeal has been used for centuries in folk and traditional medicine across Europe and North America as a topical soothing agent for itchy and inflamed skin conditions.

Scientific Evidence

Colloidal oatmeal has been used for decades to soothe and ameliorate atopic dermatitis and other pruritic and/or xerotic dermatoses. In vitro and/or in vivo studies have confirmed the anti-inflammatory, barrier repair, and moisturizing properties of this compound. A broad set of studies has been conducted in recent years to assess its effects as adjunct treatment in the management of atopic dermatitis.

In these investigations, patients in all age groups (3 months to 60 years) with mild to moderate atopic dermatitis were included and allowed to continue their prescribed topical medications. Studies found that the daily use of moisturizers and/or cleansers containing colloidal oatmeal significantly improved many clinical outcomes from baseline, including itch, dryness, and quality of life indices.

Evidence strength: Moderate for atopic and inflammatory dermatitis generally; direct clinical evidence for urushiol-induced contact dermatitis is absent. Mechanistic rationale for itch reduction and skin barrier support is well-established in vitro and in the context of atopic dermatitis.

Calendula (Calendula officinalis)

Traditional Use

Calendula has been used in European and North American herbal traditions for centuries as a topical remedy for skin inflammation, wounds, and rashes. Specific herbs and their uses developed regionally, based on locally available plants and through trade in ethnobotanical remedies. Systems of herbal use developed regionally in Europe, the Middle East, Africa, India, China, Japan, Australia, and the Americas.

Scientific Evidence

A randomized and double-blind trial compared the therapeutic efficacies of aloe vera cream and Calendula officinalis ointment on diaper dermatitis (an inflammatory skin condition) in children. Sixty-six infants were randomized to receive either aloe cream (n=32) or Calendula ointment (n=34), treated three times a day for ten days. The severity of dermatitis was graded at baseline and at trial end using a 5-point scale. Although improvement in the severity of dermatitis was observed in both treatment groups (P<0.001), patients receiving Calendula ointment had significantly fewer rash sites compared to the aloe group (P=0.001).

Evidence strength: Limited. Calendula shows anti-inflammatory benefit in some dermatitis models, but no clinical studies have specifically examined its use in urushiol-induced contact dermatitis.

Aloe Vera

Traditional Use

Aloe vera has been used in traditional medicine systems across Africa, Asia, and the Americas as a topical remedy for burns, skin irritation, and inflammatory skin conditions for thousands of years.

Scientific Evidence

Aloe vera also demonstrates bactericidal and antifungal activity in vitro. The main adverse effect of topical aloe vera gel is that it can itself cause allergic contact dermatitis in some individuals.

In the randomized comparison with Calendula for dermatitis described above, both agents produced measurable improvement in inflammatory skin lesions, with Calendula showing superior results. No clinical trials have specifically examined aloe vera for urushiol-induced dermatitis.

Evidence strength: Preliminary. Mechanistic and some clinical support exists for aloe vera in inflammatory dermatoses generally; no direct evidence for Toxicodendron dermatitis.

Homeopathic Rhus toxicodendron

Traditional Use

In homeopathic practice, highly diluted preparations of the poison ivy plant itself (Rhus toxicodendron) have been used as a traditional remedy intended to prevent or reduce the severity of urushiol-induced dermatitis, following the homeopathic principle of "like cures like."

Scientific Evidence

A case series published in Dermatology Online Journal (Signore, 2017; PMID 28329482) examined oral homeopathic Rhus toxicodendron for prevention of poison ivy dermatitis, but the evidence from this study is insufficient to draw conclusions. No large, placebo-controlled clinical trials evaluating homeopathic preparations for urushiol-induced dermatitis are available in the peer-reviewed literature.

Evidence strength: Insufficient. Only case-level evidence exists; no controlled trials are available.

Plantain (Plantago spp.) and Grindelia (Gumweed)

Traditional Use

Jewelweed and plantain both grow in the same areas as poison ivy and oak, often adjacent to their poisonous neighbors. These two herbs are most often chewed or crushed and applied as a poultice to the affected area.

Scientific Evidence

A bewildering number of herbal remedies varying widely in efficacy are suggested by both the popular and scientific literature for treating poison ivy dermatitis. This critical review summarizes existing medical data relating to these plants' capability to heal inflammatory skin disorders. Due largely to a lack of research, many remedies have scientifically unproven efficacy, such as gumweed (Grindelia spp.).

Evidence strength: Traditional use is documented; scientific evidence is absent or insufficient for both plantain and gumweed in urushiol-induced dermatitis.

Dietary and Lifestyle Factors

Cross-Reactive Foods

People who are sensitive to urushiol may experience a similar rash from mangoes, with the tree's sap and the fruit's skin containing a similar chemical compound. A related allergenic compound is present in the raw shells of cashews. Those allergic to poison ivy are also more likely to have an allergic reaction to other plant resins, such as the oil from Japanese lacquer trees (used on furniture), mango rinds, and cashew shells. Avoidance of these foods' skins and raw shells is a dietary consideration for highly sensitized individuals.

Immediate Washing After Exposure

The ideal therapy when exposed to poison oak or ivy is to wash the contaminated areas thoroughly. If done within 10–15 minutes, washing with soap and cool water can remove urushiol before it fully binds to skin. After 30 minutes, most of the oil has already penetrated and washing becomes less effective.

Occupational and Lifestyle Exposure Reduction

Contact dermatitis from plants makes up about 80% of all contact dermatitis cases and is the most common occupational skin disorder. According to the CDC, workers who experience repeated exposure face cumulative sensitization risk. Even those who have never reacted before can develop sensitivity after years on the job.

Environmental Considerations and Climate

Poison ivy responds to elevated atmospheric CO₂ levels by growing faster, accumulating more biomass, and shifting its urushiol congener composition to more allergenic congeners. Thus, poison ivy may become both more vigorous, prevalent, and noxious with expected trends of climate change.

Antioxidant-Rich Diet and Immune Modulation

Quercetin is one of the most important natural compounds with high immune modulation and anti-inflammation potency, found in various fruits and vegetables, namely onions, shallots, apples, and berry crops. Researchers have reviewed its influences against allergic conditions, including asthma, allergic rhinitis, atopic dermatitis, conjunctivitis, and anaphylaxis. While no clinical dietary intervention trials have been conducted specifically in urushiol-induced dermatitis, dietary patterns rich in flavonoid-containing foods represent a plausible area for future research in modulating allergic inflammatory responses.

Studies show that people with allergies often have low blood levels of vitamin C, making it harder for their body to balance the histamine and inflammation that drive allergy symptoms like sneezing, congestion, itching, and skin flare-ups. The clinical significance of this observation in the context of urushiol-specific reactions has not yet been tested in controlled trials.

References

• University of Massachusetts Amherst — Poison Ivy Immunology
• Johns Hopkins Medicine — Poison Ivy, Oak, and Sumac Rash
• Wikipedia — Urushiol-induced Contact Dermatitis
• Gladman AC. Toxicodendron Dermatitis: Poison Ivy, Oak, and Sumac. Wilderness & Environmental Medicine. 2006.
• CDC/NIOSH Science Bulletin — Outdoor Workers and Poisonous Plant Exposures
• Mohan JE, Ziska LH, et al. Biomass and toxicity responses of poison ivy to elevated atmospheric CO₂. PNAS. 2006;103(24):9086–9089.
• Ziska LH, Sicher RC, George K, Mohan JE. Rising Atmospheric Carbon Dioxide and Potential Impacts on the Growth and Toxicity of Poison Ivy. Weed Science. 2007;55(4):288–292.
• Long D, Ballentine NH, Marks JG Jr. Treatment of poison ivy/oak allergic contact dermatitis with an extract of jewelweed. Am J Contact Dermat. 1997;8(3):150–153.
• Abrams Motz V, Bowers CP, Mull Young L, Kinder DH. Effectiveness of jewelweed, Impatiens capensis, and lawsone in preventing post poison ivy exposure contact dermatitis. J Ethnopharmacol. 2012;143(1):314–318.
• Klemow KM et al. Medical attributes of Impatiens sp. — Jewelweed. Wilkes University.
• Weng Z et al. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS ONE. 2012;7:e33805.
• Mlcek J et al. Quercetin and Its Anti-Allergic Immune Response. Molecules. 2016;21(5):623.
• Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases. Nutrients. 2025.
• Quercetin exhibits multi-target anti-allergic effects in animal models: a systematic review and meta-analysis. Frontiers in Pharmacology. 2025.
• Kurtz ES, Wallo W. Colloidal oatmeal formulations as adjunct treatments in atopic dermatitis. J Drugs Dermatol. 2007;6(2):167–170. PMID 22777219.
• Panahi Y et al. A Randomized Comparative Trial on the Therapeutic Efficacy of Topical Aloe vera and Calendula officinalis on Diaper Dermatitis. ScientificWorldJournal. 2012:810234.
• Shenefelt PD. Herbal Treatment for Dermatologic Disorders. In: Benzie IFF, Wachtel-Galor S, eds. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. CRC Press/Taylor & Francis; 2011. NCBI Bookshelf NBK92761.
• Vollbracht C et al. Intravenous vitamin C in the treatment of allergies: an interim subgroup analysis of a long-term observational study. J Int Med Res. 2018;46(9):3640–3655.
• Fortner BR Jr et al. The effect of ascorbic acid on cutaneous and nasal response to histamine and allergen. J Allergy Clin Immunol. 1982;69(6):484–488.
• Accession-Level Differentiation of Urushiol Levels, and Identification of Cardanols in Nascent Emerged Poison Ivy Seedlings. PMC. 2019.